EE03377B1 - Farmatseutilised liposoomsüstepreparaadid - Google Patents

Farmatseutilised liposoomsüstepreparaadid

Info

Publication number: EE03377B1
Authority: EE; Estonia
Prior art keywords: phospholipid; pharmaceutical preparations; liposomal injection; cryoprotector; cooa
Prior art date: 1994-09-12

Application number

EE9500063A

Other languages

English (en)

Other versions

EE9500063A (et

Inventor

Hamann Hans-J�rgen

Serno Peter

Herboth Matthias

Kurka Peter

Original Assignee

Bayer Aktiengesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-12

Filing date

1995-09-11

Publication date

2001-04-16

1995-09-11 Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft

1996-04-15 Publication of EE9500063A publication Critical patent/EE9500063A/et

2001-04-16 Publication of EE03377B1 publication Critical patent/EE03377B1/et

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
- Y10S977/907—Liposome
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/915—Therapeutic or pharmaceutical composition

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dermatology (AREA)
Dispersion Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Toxicology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
External Artificial Organs (AREA)
Glass Compositions (AREA)

EE9500063A 1994-09-12 1995-09-11 Farmatseutilised liposoomsüstepreparaadid EE03377B1 (et)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4432378A DE4432378A1 (de)	1994-09-12	1994-09-12	Injizierbare liposomale Arzneizubereitungen

Publications (2)

Publication Number	Publication Date
EE9500063A EE9500063A (et)	1996-04-15
EE03377B1 true EE03377B1 (et)	2001-04-16

Family

ID=6527981

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EE9500063A EE03377B1 (et)	1994-09-12	1995-09-11	Farmatseutilised liposoomsüstepreparaadid

Country Status (28)

Country	Link
US (1)	US5653998A (et)
EP (1)	EP0700679B1 (et)
JP (1)	JPH0881361A (et)
KR (1)	KR960009998A (et)
CN (1)	CN1079668C (et)
AT (1)	ATE187327T1 (et)
AU (1)	AU698441B2 (et)
CA (1)	CA2157849A1 (et)
CZ (1)	CZ287975B6 (et)
DE (2)	DE4432378A1 (et)
DK (1)	DK0700679T3 (et)
EE (1)	EE03377B1 (et)
ES (1)	ES2139800T3 (et)
FI (1)	FI954204A7 (et)
GR (1)	GR3032664T3 (et)
HU (1)	HUT73808A (et)
IL (1)	IL115222A (et)
MY (1)	MY111841A (et)
NO (1)	NO311556B1 (et)
NZ (1)	NZ272943A (et)
PL (1)	PL181541B1 (et)
PT (1)	PT700679E (et)
RU (1)	RU2160099C2 (et)
SI (1)	SI0700679T1 (et)
SK (1)	SK281611B6 (et)
TW (1)	TW359616B (et)
UA (1)	UA29469C2 (et)
ZA (1)	ZA957604B (et)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6458373B1 (en) *	1997-01-07	2002-10-01	Sonus Pharmaceuticals, Inc.	Emulsion vehicle for poorly soluble drugs
DE19709704C2 (de)	1997-03-10	1999-11-04	Michael Georgieff	Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
US7030155B2 (en)	1998-06-05	2006-04-18	Sonus Pharmaceuticals, Inc.	Emulsion vehicle for poorly soluble drugs
KR20000003433A (ko) *	1998-06-29	2000-01-15	김영환	반도체소자의 커패시터 제조방법
ATE397488T1 (de) *	1998-11-13	2008-06-15	Heriot William A	Vorrichtung zur herstellung von liposomen
HK1044897A1 (zh) *	1999-05-14	2002-11-08	Esperion Luv Development Inc.	心绞痛和/或不典型心绞痛的治疗方法及其相关药物组合物和药剂盒
EP1259225B1 (en)	2000-02-04	2006-10-04	Lipoxen Technologies Limited	Process of dehydration/rehydration for making liposomes
US20060177416A1 (en)	2003-10-14	2006-08-10	Medivas, Llc	Polymer particle delivery compositions and methods of use
EP1530465B2 (en)	2002-06-26	2015-12-16	MediGene AG	Method of producing a cationic liposomal preparation comprising a lipophilic compound
DE10255195A1 (de)	2002-11-27	2004-06-09	Lipoid Gmbh	Micellare wasserlösliche Konzentrate
WO2005002546A1 (en) *	2003-06-27	2005-01-13	Smithkline Beecham Corporation	Stabilized topotecan liposomal composition and methods
US7345093B2 (en) *	2004-04-27	2008-03-18	Formatech, Inc.	Methods of enhancing solubility of compounds
WO2006094203A1 (en) *	2005-03-02	2006-09-08	Northeastern University	Mitochondriotropic phospholipid vesicles
SI1888033T1 (sl) *	2005-06-09	2014-06-30	Meda Ab	Postopek in sestavek za zdravljenje vnetnih motenj
JP5178520B2 (ja)	2005-09-22	2013-04-10	メディバスエルエルシー	固体ポリマー送達組成物およびその使用法
JP5192384B2 (ja)	2005-09-22	2013-05-08	メディバスエルエルシー	ビス−（α−アミノ）−ジオール−ジエステル含有ポリ（エステルアミド）およびポリ（エステルウレタン）組成物および使用の方法
WO2008000534A1 (de) *	2006-06-30	2008-01-03	Gertrud Langhoff	Solubilisatformulierungen
JP6081058B2 (ja) *	2009-03-19	2017-02-15	第一三共株式会社	包装により安定保存された固形製剤
US10143652B2 (en)	2009-09-23	2018-12-04	Curirx Inc.	Methods for the preparation of liposomes
US20110070293A1 (en) *	2009-09-23	2011-03-24	Javeri Indu	Methods for the Preparation of Liposomes Comprising Docetaxel
US20110070294A1 (en) *	2009-09-23	2011-03-24	Javeri Indu	Methods for the Administration of Drugs Using Liposomes
IT1404011B1 (it)	2010-12-03	2013-11-08	Uni Degli Studi Magna Graecia Di Catanzaro	Nanovettore coniugato con tsh per il trattamento del cancro della tiroide
PL226015B1 (pl) *	2011-03-03	2017-06-30	Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną	Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna
CN103748139B (zh)	2011-06-23	2016-08-17	帝斯曼知识产权资产管理有限公司	用于递送生物活性剂的包含生物可降解的聚酯酰胺共聚物的微米颗粒或纳米颗粒
US9873765B2 (en)	2011-06-23	2018-01-23	Dsm Ip Assets, B.V.	Biodegradable polyesteramide copolymers for drug delivery
FR2979239A1 (fr) *	2011-08-25	2013-03-01	Trophos	Liposome comprenant au moins un derive de cholesterol
EP2682106A1 (en)	2012-07-03	2014-01-08	Phares Pharmaceutical Research N.V.	Method of solubilizing biologically active compounds
CA2893342A1 (en) *	2012-12-06	2014-06-12	D & J Rosee Inc.	Topical liposome compositions containing phenolic anti-inflammatory agents and their methods of preparation
JP6720447B2 (ja)	2014-12-18	2020-07-08	ディーエスエムアイピーアセッツビー．ブイ．ＤｓｍＩｐＡｓｓｅｔｓＢ．Ｖ．	酸感受性薬剤の送達のための薬剤送達系
CN110898011B (zh) *	2019-11-27	2022-02-08	西南医科大学	一种依托咪酯纳米制剂及其制备方法
KR20220125259A (ko) *	2019-12-23	2022-09-14	잠본쏘시에떼퍼아찌오니	흡입성 면역억제 활성 성분을 포함하는 분산액의 제조 방법
JP7608086B2 (ja) *	2020-07-31	2025-01-06	東和薬品株式会社	シームレスカプセル

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3515335C2 (de) *	1985-04-27	1995-01-26	Bayer Ag	Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung
DE4117750A1 (de) *	1991-05-30	1992-12-24	Bayer Ag	Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4207481A1 (de) *	1992-03-10	1993-09-16	Bayer Ag	Liposomale wirkstoff-formulierungen und verfahren zu ihrer herstellung

1994
- 1994-09-12 DE DE4432378A patent/DE4432378A1/de not_active Withdrawn
1995
- 1995-08-28 MY MYPI95002551A patent/MY111841A/en unknown
- 1995-08-30 PT PT95113608T patent/PT700679E/pt unknown
- 1995-08-30 DK DK95113608T patent/DK0700679T3/da active
- 1995-08-30 ES ES95113608T patent/ES2139800T3/es not_active Expired - Lifetime
- 1995-08-30 AT AT95113608T patent/ATE187327T1/de not_active IP Right Cessation
- 1995-08-30 TW TW084109031A patent/TW359616B/zh active
- 1995-08-30 EP EP95113608A patent/EP0700679B1/de not_active Expired - Lifetime
- 1995-08-30 SI SI9530334T patent/SI0700679T1/xx unknown
- 1995-08-30 DE DE59507372T patent/DE59507372D1/de not_active Expired - Fee Related
- 1995-09-05 US US08/523,662 patent/US5653998A/en not_active Expired - Fee Related
- 1995-09-05 AU AU30464/95A patent/AU698441B2/en not_active Ceased
- 1995-09-06 JP JP7252061A patent/JPH0881361A/ja active Pending
- 1995-09-06 NZ NZ272943A patent/NZ272943A/en unknown
- 1995-09-06 UA UA95094063A patent/UA29469C2/uk unknown
- 1995-09-08 IL IL11522295A patent/IL115222A/xx active IP Right Grant
- 1995-09-08 CA CA002157849A patent/CA2157849A1/en not_active Abandoned
- 1995-09-08 FI FI954204A patent/FI954204A7/fi unknown
- 1995-09-08 PL PL95310344A patent/PL181541B1/pl unknown
- 1995-09-11 RU RU95115542/14A patent/RU2160099C2/ru active
- 1995-09-11 CZ CZ19952341A patent/CZ287975B6/cs not_active IP Right Cessation
- 1995-09-11 NO NO19953578A patent/NO311556B1/no not_active IP Right Cessation
- 1995-09-11 KR KR1019950029487A patent/KR960009998A/ko not_active Abandoned
- 1995-09-11 SK SK1127-95A patent/SK281611B6/sk unknown
- 1995-09-11 EE EE9500063A patent/EE03377B1/et not_active IP Right Cessation
- 1995-09-11 ZA ZA957604A patent/ZA957604B/xx unknown
- 1995-09-12 HU HU9502654A patent/HUT73808A/hu unknown
- 1995-09-12 CN CN95115156A patent/CN1079668C/zh not_active Expired - Fee Related
2000
- 2000-02-14 GR GR20000400362T patent/GR3032664T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
ATE187327T1 (de)	1999-12-15
SK281611B6 (sk)	2001-05-10
TW359616B (en)	1999-06-01
UA29469C2 (uk)	2000-11-15
HU9502654D0 (en)	1995-11-28
NO953578D0 (no)	1995-09-11
AU3046495A (en)	1996-03-28
ES2139800T3 (es)	2000-02-16
IL115222A0 (en)	1995-12-31
EP0700679A1 (de)	1996-03-13
FI954204L (fi)	1996-03-13
DK0700679T3 (da)	2000-05-29
ZA957604B (en)	1996-04-15
CZ287975B6 (cs)	2001-03-14
DE59507372D1 (de)	2000-01-13
PL181541B1 (pl)	2001-08-31
CA2157849A1 (en)	1996-03-13
US5653998A (en)	1997-08-05
EE9500063A (et)	1996-04-15
NO311556B1 (no)	2001-12-10
SK112795A3 (en)	1997-02-05
FI954204A7 (fi)	1996-03-13
SI0700679T1 (en)	2000-02-29
NZ272943A (en)	1996-07-26
EP0700679B1 (de)	1999-12-08
CZ234195A3 (en)	1996-03-13
JPH0881361A (ja)	1996-03-26
KR960009998A (ko)	1996-04-20
IL115222A (en)	1999-06-20
AU698441B2 (en)	1998-10-29
PT700679E (pt)	2000-05-31
MY111841A (en)	2001-01-31
NO953578L (no)	1996-03-13
GR3032664T3 (en)	2000-06-30
PL310344A1 (en)	1996-03-18
DE4432378A1 (de)	1996-03-14
FI954204A0 (fi)	1995-09-08
CN1079668C (zh)	2002-02-27
RU2160099C2 (ru)	2000-12-10
CN1128655A (zh)	1996-08-14
HUT73808A (en)	1996-09-30

Publication	Publication Date	Title
EE03377B1 (et)	2001-04-16	Farmatseutilised liposoomsüstepreparaadid
US4956173A (en)	1990-09-11	Composition and use of ademetionine against ageing of the skin
US4760096A (en)	1988-07-26	Moisturizing skin preparation
Santoyo et al.	1995	Penetration enhancer effects on the in vitro percutaneous absorption of piroxicam through rat skin
PT742011E (pt)	2002-10-31	Preparacao que pode ser absorvida por via percutanea
CA2162993A1 (en)	1994-11-24	Solid fat nanoemulsions as drug delivery vehicles
ES2088385T3 (es)	1996-08-16	Formulaciones de liposomas con una elevada relacion agente antineoplasico/lipido.
NO20000465L (no)	2000-03-28	Farmasøytisk preparat i form av en selvemulgerende formulering for lipofile forbindelser
DK434187D0 (da)	1987-08-20	Injektionspraeparat omfattende i phospholipidpartikler indkapslede antifungale polyen-antibiotika
DK0830145T3 (da)	2000-10-09	Formuleringer omfattende leflunomid
US5219880A (en)	1993-06-15	Treatment of viral tumors and hemorrhoids with artemisinin and derivatives
PT94110B (pt)	1996-12-31	Processo para a preparacao de composicoes cosmeticas, que se opoem ao envelhecimento da pele,contendo betaina
ES2086802T3 (es)	1996-07-01	Formulaciones liposomicas de principios activos y procedimiento para su preparacion.
FI861695A0 (fi)	1986-04-22	Farmaceutiskt preparat och foerfarande foer administrering daerav.
AU2809697A (en)	1997-11-12	Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
TH20333A (th)	1996-09-03	สารเตรียมทางยาไลโปโซมอลที่สามารถฉีดได้
ES2141049A1 (es)	2000-03-01	Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes.
TH20138B (th)	2006-07-05	สารที่เตรียมขึ้นสำหรับผิวชั้นนอก

Legal Events

Date	Code	Title	Description
2003-02-17	KB4A	Valid patent at the end of a year	Effective date: 20021231
2003-06-16	MM4A	Lapsed by not paying the annual fees	Effective date: 20020911